SCHEMBL17545359

SCHEMBL17545359

O=C(OCc1ccccc1)N1CCc2cccc(S(=O)(=O)Cl)c21

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
NOTUM Q6P988 2/20 0.46
TMEM97 Q5BJF2 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
PARP1 P09874 1/20 0.42
MGAT2 Q10469 4/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17545335 0.88 RAB9A (0.60) NPC1RAB9AL3MBTL1NOTUMTMEM97
SCHEMBL19219776 0.84 NPC1 (0.53) NPC1RAB9AL3MBTL1NOTUMTMEM97
SCHEMBL18391875 0.84 NPC1 (0.55) NPC1RAB9AL3MBTL1NOTUMTMEM97
SCHEMBL18391876 0.83 NPC1 (0.54) NPC1RAB9AL3MBTL1NOTUMTMEM97
SCHEMBL17545409 0.78 NOTUM (0.47) NOTUMGAAMAPK1
SCHEMBL18391877 0.77 RAB9A (0.47) NPC1RAB9AL3MBTL1KMT2ASMN1; SMN2
SCHEMBL19219780 0.77 NOTUM (0.66) NOTUMNPSR1SMN1; SMN2GAAMAPK1
SCHEMBL30659283 0.76 NPC1 (1.00) NPC1RAB9AL3MBTL1NOTUMTMEM97
SCHEMBL7469639 0.76 NPC1 (1.00) NPC1RAB9AL3MBTL1NOTUMTMEM97
SCHEMBL19219777 0.76 RAB9A (0.53) NPC1RAB9AL3MBTL1NOTUMTMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016025637-A1 INDOLINE SULFONAMIDE INHIBITORS OF DAPE AND NDM-1 AND USE OF THE SAME LOYOLA UNIVERSITY OF CHICAGO (US) 2016-02-18 WO disclosed